CLINICAL_TRIALS
trial_result
· 2014-01-31
Clinical Trial Update: Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder [Phase 2]
Summary
Phase 2 trial assessing a substance P antagonist for posttraumatic stress disorder has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2014-01-31